HEADER ANTIVIRAL PROTEIN 03-APR-22 7ZGE TITLE BRXA, BREX PHAGE DEFENCE PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BRXA, BREX PHAGE DEFENCE PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: DUF1819 FAMILY PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA FERGUSONII ATCC 35469; SOURCE 3 ORGANISM_TAXID: 585054; SOURCE 4 STRAIN: ATCC 35469 / DSM 13698 / CCUG 18766 / IAM 14443 / JCM 21226 SOURCE 5 / LMG 7866 / NBRC 102419 / NCTC 12128 / CDC 0568-73; SOURCE 6 GENE: EFER_P0021; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS BREX PHAGE DEFENCE BACTERIOPHAGE EXCLUSION, ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.M.PICTON,I.N.BECK,T.R.BLOWER REVDAT 4 20-MAR-24 7ZGE 1 TITLE COMPND REVDAT 3 31-JAN-24 7ZGE 1 REMARK REVDAT 2 29-JUN-22 7ZGE 1 JRNL REVDAT 1 22-JUN-22 7ZGE 0 JRNL AUTH B.USHER,N.BIRKHOLZ,I.N.BECK,R.D.FAGERLUND,S.A.JACKSON, JRNL AUTH 2 P.C.FINERAN,T.R.BLOWER JRNL TITL CRYSTAL STRUCTURE OF THE ANTI-CRISPR REPRESSOR ACA2. JRNL REF J.STRUCT.BIOL. V. 213 07752 2021 JRNL REFN ESSN 1095-8657 JRNL PMID 34116143 JRNL DOI 10.1016/J.JSB.2021.107752 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH I.N.BECK,D.M.PICTON,T.R.BLOWER REMARK 1 TITL CRYSTAL STRUCTURE OF THE BREX PHAGE DEFENCE PROTEIN BRXA REMARK 1 REF CURR RES STRUCT BIOL 2022 REMARK 1 REFN ESSN 2665-928X REMARK 1 DOI 10.1016/J.CRSTBI.2022.06.001 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.V.AFONINE,R.W.GROSSE-KUNSTLEVE,N.ECHOLS,J.J.HEADD, REMARK 1 AUTH 2 N.W.MORIARTY,M.MUSTYAKIMOV,T.C.TERWILLIGER,A.URZHUMTSEV, REMARK 1 AUTH 3 P.H.ZWART,P.D.ADAMS REMARK 1 TITL TOWARDS AUTOMATED CRYSTALLOGRAPHIC STRUCTURE REFINEMENT WITH REMARK 1 TITL 2 PHENIX.REFINE. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 68 352 2012 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 22505256 REMARK 1 DOI 10.1107/S0907444912001308 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX. REMARK 1 REF ACTA CRYSTALLOGR D STRUCT V. 75 861 2019 REMARK 1 REF 2 BIOL REMARK 1 REFN ISSN 2059-7983 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 37280 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 1801 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.5300 - 4.9100 1.00 2867 143 0.2012 0.2442 REMARK 3 2 4.9100 - 3.9000 1.00 2754 149 0.1768 0.2079 REMARK 3 3 3.9000 - 3.4100 1.00 2764 150 0.1989 0.2332 REMARK 3 4 3.4100 - 3.1000 1.00 2744 127 0.2219 0.2871 REMARK 3 5 3.1000 - 2.8700 1.00 2729 139 0.2316 0.2872 REMARK 3 6 2.8700 - 2.7000 1.00 2719 138 0.2417 0.2922 REMARK 3 7 2.7000 - 2.5700 1.00 2709 144 0.2440 0.2945 REMARK 3 8 2.5700 - 2.4600 1.00 2712 140 0.2531 0.2856 REMARK 3 9 2.4600 - 2.3600 1.00 2689 135 0.2631 0.3133 REMARK 3 10 2.3600 - 2.2800 1.00 2754 146 0.2714 0.3361 REMARK 3 11 2.2800 - 2.2100 1.00 2663 142 0.3148 0.3595 REMARK 3 12 2.2100 - 2.1500 1.00 2738 123 0.3332 0.3501 REMARK 3 13 2.1500 - 2.0900 0.97 2637 125 0.3518 0.3785 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.338 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.812 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4736 REMARK 3 ANGLE : 1.116 6384 REMARK 3 CHIRALITY : 0.054 736 REMARK 3 PLANARITY : 0.006 793 REMARK 3 DIHEDRAL : 19.170 1800 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZGE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292122215. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : DIALS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37354 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 42.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3BHW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M (NH4)2SO4, 0.1 M N-(2 REMARK 280 -ACETAMIDO)IMINODIACETIC ACID (ADA, PH 6.5), 18% V/V PEG SMEAR REMARK 280 HIGH, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 87.21200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.26950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 87.21200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.26950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS C 29 REMARK 465 LYS C 30 REMARK 465 LEU C 31 REMARK 465 PRO C 32 REMARK 465 GLU C 33 REMARK 465 ASP C 34 REMARK 465 GLU C 35 REMARK 465 TRP C 36 REMARK 465 GLN C 47 REMARK 465 LYS C 48 REMARK 465 LYS C 49 REMARK 465 SER C 50 REMARK 465 GLY C 51 REMARK 465 GLN C 52 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 -137.27 -106.24 REMARK 500 VAL A 41 -61.85 -92.40 REMARK 500 LEU A 68 -174.89 -66.47 REMARK 500 GLU A 193 -59.71 -25.03 REMARK 500 SER B 14 -141.50 -99.80 REMARK 500 ASN B 44 58.88 38.97 REMARK 500 GLN B 47 94.81 -64.76 REMARK 500 SER B 80 176.49 -57.88 REMARK 500 SER B 96 67.94 -119.52 REMARK 500 SER C 14 -138.04 -100.63 REMARK 500 THR C 113 21.85 -75.25 REMARK 500 ASP C 121 63.64 -118.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 267 DISTANCE = 9.14 ANGSTROMS DBREF 7ZGE A 1 199 UNP B7L3Y4 B7L3Y4_ESCF3 1 199 DBREF 7ZGE B 1 199 UNP B7L3Y4 B7L3Y4_ESCF3 1 199 DBREF 7ZGE C 1 199 UNP B7L3Y4 B7L3Y4_ESCF3 1 199 SEQRES 1 A 199 MET ASN ILE LYS GLU TYR LEU GLY ASP LEU ILE GLY SER SEQRES 2 A 199 SER LEU LEU ILE THR GLU SER ARG ILE ILE ALA GLU SER SEQRES 3 A 199 LEU LEU LYS LYS LEU PRO GLU ASP GLU TRP LYS SER LEU SEQRES 4 A 199 ILE VAL GLU GLN ASN VAL LEU GLN LYS LYS SER GLY GLN SEQRES 5 A 199 THR ALA ILE ARG TYR ALA ARG THR ILE ARG TRP ARG ILE SEQRES 6 A 199 GLU GLY LEU GLY ASP GLU PHE MET THR ASP LEU LEU ALA SEQRES 7 A 199 ALA SER GLU ARG ALA TYR ILE GLN MET LEU MET MET SER SEQRES 8 A 199 LEU LEU ILE HIS SER PRO VAL VAL ALA ASP PHE MET ARG SEQRES 9 A 199 HIS THR LEU ALA GLU ALA ARG ARG THR TYR LYS PRO ALA SEQRES 10 A 199 LEU THR ALA ASP ALA TRP SER GLU PHE TYR ASP THR ARG SEQRES 11 A 199 VAL ARG ALA TYR ALA GLU LEU GLY GLY PHE SER ASP SER SEQRES 12 A 199 THR ILE LYS LYS MET GLY ASN ASN ALA ILE LYS ALA LEU SEQRES 13 A 199 VAL ASP SER GLY TYR LEU SER ASP SER ARG THR LYS LYS SEQRES 14 A 199 ILE GLN PRO VAL TYR LEU MET PRO GLU VAL LYS ASP TRP SEQRES 15 A 199 LEU VAL ARG LEU GLY ARG GLU ASP LEU ILE GLU VAL MET SEQRES 16 A 199 GLU CYS THR ILE SEQRES 1 B 199 MET ASN ILE LYS GLU TYR LEU GLY ASP LEU ILE GLY SER SEQRES 2 B 199 SER LEU LEU ILE THR GLU SER ARG ILE ILE ALA GLU SER SEQRES 3 B 199 LEU LEU LYS LYS LEU PRO GLU ASP GLU TRP LYS SER LEU SEQRES 4 B 199 ILE VAL GLU GLN ASN VAL LEU GLN LYS LYS SER GLY GLN SEQRES 5 B 199 THR ALA ILE ARG TYR ALA ARG THR ILE ARG TRP ARG ILE SEQRES 6 B 199 GLU GLY LEU GLY ASP GLU PHE MET THR ASP LEU LEU ALA SEQRES 7 B 199 ALA SER GLU ARG ALA TYR ILE GLN MET LEU MET MET SER SEQRES 8 B 199 LEU LEU ILE HIS SER PRO VAL VAL ALA ASP PHE MET ARG SEQRES 9 B 199 HIS THR LEU ALA GLU ALA ARG ARG THR TYR LYS PRO ALA SEQRES 10 B 199 LEU THR ALA ASP ALA TRP SER GLU PHE TYR ASP THR ARG SEQRES 11 B 199 VAL ARG ALA TYR ALA GLU LEU GLY GLY PHE SER ASP SER SEQRES 12 B 199 THR ILE LYS LYS MET GLY ASN ASN ALA ILE LYS ALA LEU SEQRES 13 B 199 VAL ASP SER GLY TYR LEU SER ASP SER ARG THR LYS LYS SEQRES 14 B 199 ILE GLN PRO VAL TYR LEU MET PRO GLU VAL LYS ASP TRP SEQRES 15 B 199 LEU VAL ARG LEU GLY ARG GLU ASP LEU ILE GLU VAL MET SEQRES 16 B 199 GLU CYS THR ILE SEQRES 1 C 199 MET ASN ILE LYS GLU TYR LEU GLY ASP LEU ILE GLY SER SEQRES 2 C 199 SER LEU LEU ILE THR GLU SER ARG ILE ILE ALA GLU SER SEQRES 3 C 199 LEU LEU LYS LYS LEU PRO GLU ASP GLU TRP LYS SER LEU SEQRES 4 C 199 ILE VAL GLU GLN ASN VAL LEU GLN LYS LYS SER GLY GLN SEQRES 5 C 199 THR ALA ILE ARG TYR ALA ARG THR ILE ARG TRP ARG ILE SEQRES 6 C 199 GLU GLY LEU GLY ASP GLU PHE MET THR ASP LEU LEU ALA SEQRES 7 C 199 ALA SER GLU ARG ALA TYR ILE GLN MET LEU MET MET SER SEQRES 8 C 199 LEU LEU ILE HIS SER PRO VAL VAL ALA ASP PHE MET ARG SEQRES 9 C 199 HIS THR LEU ALA GLU ALA ARG ARG THR TYR LYS PRO ALA SEQRES 10 C 199 LEU THR ALA ASP ALA TRP SER GLU PHE TYR ASP THR ARG SEQRES 11 C 199 VAL ARG ALA TYR ALA GLU LEU GLY GLY PHE SER ASP SER SEQRES 12 C 199 THR ILE LYS LYS MET GLY ASN ASN ALA ILE LYS ALA LEU SEQRES 13 C 199 VAL ASP SER GLY TYR LEU SER ASP SER ARG THR LYS LYS SEQRES 14 C 199 ILE GLN PRO VAL TYR LEU MET PRO GLU VAL LYS ASP TRP SEQRES 15 C 199 LEU VAL ARG LEU GLY ARG GLU ASP LEU ILE GLU VAL MET SEQRES 16 C 199 GLU CYS THR ILE FORMUL 4 HOH *202(H2 O) HELIX 1 AA1 ASN A 2 GLY A 8 1 7 HELIX 2 AA2 LEU A 16 LEU A 28 1 13 HELIX 3 AA3 ASP A 34 VAL A 41 1 8 HELIX 4 AA4 SER A 50 GLU A 66 1 17 HELIX 5 AA5 GLY A 69 ALA A 79 1 11 HELIX 6 AA6 SER A 80 SER A 96 1 17 HELIX 7 AA7 SER A 96 THR A 106 1 11 HELIX 8 AA8 THR A 106 THR A 113 1 8 HELIX 9 AA9 ASP A 121 TYR A 134 1 14 HELIX 10 AB1 ALA A 135 GLY A 139 5 5 HELIX 11 AB2 SER A 141 SER A 159 1 19 HELIX 12 AB3 MET A 176 GLY A 187 1 12 HELIX 13 AB4 GLU A 189 GLU A 196 1 8 HELIX 14 AB5 ASN B 2 GLY B 8 1 7 HELIX 15 AB6 LEU B 16 LYS B 29 1 14 HELIX 16 AB7 PRO B 32 GLN B 43 1 12 HELIX 17 AB8 GLN B 52 GLU B 66 1 15 HELIX 18 AB9 GLY B 69 ALA B 79 1 11 HELIX 19 AC1 SER B 80 SER B 96 1 17 HELIX 20 AC2 SER B 96 THR B 106 1 11 HELIX 21 AC3 THR B 106 THR B 113 1 8 HELIX 22 AC4 ASP B 121 TYR B 134 1 14 HELIX 23 AC5 ALA B 135 GLY B 139 5 5 HELIX 24 AC6 SER B 141 SER B 159 1 19 HELIX 25 AC7 MET B 176 LEU B 186 1 11 HELIX 26 AC8 ARG B 188 ASP B 190 5 3 HELIX 27 AC9 LEU B 191 GLU B 196 1 6 HELIX 28 AD1 ASN C 2 GLY C 8 1 7 HELIX 29 AD2 LEU C 16 LEU C 28 1 13 HELIX 30 AD3 SER C 38 ASN C 44 1 7 HELIX 31 AD4 ALA C 54 GLU C 66 1 13 HELIX 32 AD5 GLY C 69 ALA C 79 1 11 HELIX 33 AD6 SER C 80 SER C 96 1 17 HELIX 34 AD7 SER C 96 THR C 106 1 11 HELIX 35 AD8 THR C 106 THR C 113 1 8 HELIX 36 AD9 ASP C 121 TYR C 134 1 14 HELIX 37 AE1 ALA C 135 GLY C 139 5 5 HELIX 38 AE2 SER C 141 SER C 159 1 19 HELIX 39 AE3 MET C 176 LEU C 186 1 11 HELIX 40 AE4 GLU C 189 GLU C 196 1 8 CRYST1 174.424 42.539 86.839 90.00 102.74 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005733 0.000000 0.001297 0.00000 SCALE2 0.000000 0.023508 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011806 0.00000